Morgan Stanley Nevro Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Nevro Corp stock. As of the latest transaction made, Morgan Stanley holds 1,037,259 shares of NVRO stock, worth $4.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,037,259

Previous 337,764 207.1%

Holding current value

$4.69 Million

Previous $2.84 Million 103.55%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $3.29 Million - $7.06 Million	699,495 Added 207.1%	1,037,259 $5.79 Million
Q2 2024 Oct 17, 2024	SELL	$7.96 - $13.59 $2.71 Million - $4.63 Million	-341,006 Reduced 50.24%	337,764 $2.84 Million
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $2.71 Million - $4.63 Million	-341,006 Reduced 50.24%	337,764 $2.84 Million
Q1 2024 Oct 17, 2024	BUY	$13.56 - $20.78 $4.62 Million - $7.09 Million	341,006 Added 100.96%	678,770 $9.8 Million
Q1 2024 Aug 16, 2024	BUY	$13.56 - $20.78 $2.29 Million - $3.51 Million	169,104 Added 33.18%	678,770 $9.8 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $2.29 Million - $3.51 Million	169,104 Added 33.18%	678,770 $9.8 Million
Q4 2023 Aug 16, 2024	BUY	$14.18 - $22.31 $2.44 Million - $3.84 Million	171,902 Added 50.89%	509,666 $11 Million
Q4 2023 Feb 13, 2024	BUY	$14.18 - $22.31 $2.78 Million - $4.37 Million	195,980 Added 62.48%	509,666 $11 Million
Q3 2023 Nov 15, 2023	SELL	$18.22 - $25.85 $1.57 Million - $2.23 Million	-86,319 Reduced 21.58%	313,686 $6.03 Million
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $422,405 - $734,261	-18,674 Reduced 4.46%	400,005 $10.2 Million
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $3.78 Million - $5.15 Million	-125,339 Reduced 23.04%	418,679 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $4.08 Million - $5.53 Million	111,947 Added 25.91%	544,018 $21.5 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $2.75 Million - $3.59 Million	-67,696 Reduced 13.55%	432,071 $20.1 Million
Q2 2022 Oct 27, 2022	SELL	$40.85 - $77.67 $68,423 - $130,097	-1,675 Reduced 0.33%	499,767 $21.9 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $68,423 - $130,097	-1,675 Reduced 0.33%	499,767 $21.9 Million
Q1 2022 Oct 27, 2022	BUY	$59.95 - $92.06 $100,416 - $154,200	1,675 Added 0.34%	501,442 $36.3 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $8.74 Million - $13.4 Million	145,743 Added 40.97%	501,442 $36.3 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $4.16 Million - $6.22 Million	51,262 Added 16.84%	355,699 $28.8 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $31 Million - $50.6 Million	304,437 New	304,437 $35.4 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account